Exclusive Interview with MediPharm Labs Co-Founder and President Keith Strachan MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ), focused solely on producing cannabis concentrates, has a leading revenue position...
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
MediPharm Labs Reports Strong, Profitable 2019 Third Quarter While Investing for Future Global Advantage Revenue $43.4 million, adjusted EBITDA $10.1 million BARRIE, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) —...
BARRIE, Ontario, Nov. 05, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and...
BARRIE, Ontario, Nov. 04, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
After a 57.4% gain in Q1, the Global Cannabis Stock Index moved sharply lower again in October, its seventh consecutive monthly decline, as it lost 11.2% to 47.29: The index,...
Losses mounted for Canadian licensed producers in October, with the Canadian Cannabis LP Index falling 18.2% to 481.91, the seventh consecutive monthly loss: The index remains substantially below the all-time closing...
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
BARRIE, Ontario, Oct. 31, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
BARRIE, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
Access to Applied Research Opportunities Donation of $100,000 of Cannabis Derivatives Towards Studies Hiring of Interns & Hosting Annual Cohort for Educational Lectures BARRIE, Ontario, Oct. 23, 2019 (GLOBE...
MediPharm Labs Enters New Beverages and Culinary Lifestyle Market Through Cannabis Concentrate Supply Partnership with Tea and Edibles Company Olli Brands Inc. TORONTO, Oct. 16, 2019 (GLOBE NEWSWIRE) —...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
TORONTO, Oct. 10, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
MediPharm Labs receives permits for additional Canadian exports of medical cannabis concentrate to Australia and completes related shipments Australian exports represent a 137% greater volume compared to first export...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
MediPharm Labs to supply TerrAscend with large volumes of high-quality CBD and THC distillate Multi-Year supply agreement to support TerrAscend’s roll out of Canadian Cannabis 2.0 derivative products TORONTO,...
MediPharm Labs Enters European Medical Cannabis Market with German Pharmaceutical and Medical Cannabis Distributor ADREXpharma® First extraction-only company with supply agreement for export to Germany Second international distribution milestone...
TORONTO, Sept. 20, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and...
MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement MediPharm to produce high-quality cannabis concentrate filled vapes for Cronos Group Deal reinforces MediPharm Labs’ leadership in large...
MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership Construction of New Melbourne-area Extraction Facility on Schedule Further...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index has done a complete round-trip, with the index extending its losing streak to five months after declining in August by...
TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction,...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
